Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
Clinical trial NCT06863532 · RECRUITING
Trial details
- NCT number
- NCT06863532
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-30
- Primary completion
- 2026-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.